ARCHIVES

Aranesp Improved Anemia In MDS In Phase II Trial

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Why Four? NCI Official Challenged To Explain Rational For Proposed Number Of Groups

March 25, 2011

Panel Clear On Breast Conservation, Not On Adjuvant Therapy For Node

June 29, 1990

Commercial Labs Open Drive To Get More NIH Business, Including Grants

April 26, 1974

FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications

September 4, 2009

RFPs Available

May 5, 2000

CDC Contribution To National Dialogue Raises Questions About Ties With ACS.

September 22, 2000